Goldman Sachs’s Sharps Compliance Corp SMED Stock Holding History

Goldman Sachs’s Portfolio SMED Stock Details SMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-91,976	Closed	-$268K	–	6819
2022 Q2	$268K	Sell	91,976 -555,740	-86%	-$2.32M	﹤0.01%	5489
2022 Q1	$3.82M	Sell	647,716 -19,061	-3%	-$120K	﹤0.01%	3613
2021 Q4	$4.75M	Buy	666,777 +174,370	+35%	+$1.34M	﹤0.01%	3461
2021 Q3	$4.07M	Buy	492,407 +381,522	+344%	+$3.55M	﹤0.01%	3522
2021 Q2	$1.14M	Buy	+110,885	New	+$1.54M	﹤0.01%	4663
2021 Q1	–	Sell	-12,458	Closed	-$118K	–	6469
2020 Q4	$118K	Buy	+12,458	New	+$95.3K	﹤0.01%	5265

Goldman Sachs's SMED Position: Q3 2022 in Review

Goldman Sachs sold out of Sharps Compliance Corp (SMED) in Q3 2022, closing a stake of 91,976 shares — an estimated $268K sold.

Goldman Sachs first reported a position in SMED in Q4 2020 and held it in 6 quarters. The position peaked at $4.75M in Q4 2021. 0 funds tracked by Wall St. Rank hold SMED as of Q3 2022.

Goldman Sachs reported no remaining Sharps Compliance Corp position as of Q3 2022 after selling out during the quarter.
Goldman Sachs sold 91,976 Sharps Compliance Corp shares in Q3 2022, an estimated $268K.
Goldman Sachs first reported a position in Sharps Compliance Corp in Q4 2020 and held it in 6 quarters.
Goldman Sachs's Sharps Compliance Corp position peaked at $4.75M in Q4 2021.
0 funds tracked by Wall St. Rank held Sharps Compliance Corp as of Q3 2022.

Based on Goldman Sachs's 13F filing for Q3 2022, filed 14 Nov 2022.